> News
 > Microbiotica unveils multiple mechanisms by which MB310, in clinical development for the treatment of ulcerative colitis, protects the intestinal barrier
News
09/05/2025

Microbiotica unveils multiple mechanisms by which MB310, in clinical development for the treatment of ulcerative colitis, protects the intestinal barrier

Read the full article below.

microbiotica

Our news

News
10/06/2025
The “Microbiome Times Forum” brought together key experts to shape the future of microbiome innovation in the European Union
> READ
News
08/11/2024
EMIH is a partner of the 8th edition of the Microbiota and Health Day organized by Lyonbiopôle Auvergne-Rhône-Alpes.
> READ
News
09/07/2026
Biofortis obtains ANSM authorization and strengthens its position in the development of microbiota-derived therapies
> READ
> See all news

EMIH has launched Europe’s First AI & Microbiome Bootcamp